Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
about
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyDual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell modelDefining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum.Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapyEvaluation of biodistribution and safety of adenovirus vector containing MDR1 in miceNoninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor modelAd5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous deliveryAdenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma.p53 gene in treatment of hepatic carcinoma: status quo.Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives.The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Genomic landscape of gastric cancer: molecular classification and potential targets.Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.Gene therapy that inhibits NF-kappaB results in apoptosis of human hepatocarcinoma by recombinant adenovirus.Hepatic Intra-arterial Delivery of a "Trojan-horses" Gene Therapy: A Pilot Study on Rabbit VX2 Hepatic Tumor Model.Improving adenoviral vectors and strategies for prostate cancer gene therapy
P2860
Q27001601-49BEFD74-F2A0-4A6B-A45F-58C8511EED64Q28545864-9CEE25F6-2D25-42E9-BA6D-840AE3FD5C1CQ33440718-EA0D0E2A-F514-4D7E-8458-C67E2B4D59A5Q33633277-AF89B762-3D50-44CB-A446-98959A7B72DBQ33640779-85544E86-C225-44D2-8039-25B997C9CD05Q34769352-1F97B398-C2B3-494E-86B1-83588ECC482AQ36445557-C99994EE-1288-4D6E-8109-EF703DB10016Q36496709-9824FB22-AC51-4460-98DF-8A4571C35B97Q36764842-E1BE0794-684F-4960-9B46-B7713CFAEB35Q37513298-500469F2-7947-43A4-AC13-BD5AD256758CQ38008337-3EE65AAF-5BD2-471B-9B3A-0C815FB74AC0Q38099680-9B6E2C8D-B99A-4CD7-8E50-C6324DE6EF1CQ38230901-D648DB9D-F2C2-4C15-9DE6-820B6D97171EQ38614156-17BCDE96-250E-4BE1-9BBA-E1A22D674E09Q38837669-A1D535ED-0CEA-4A21-B0E3-84CAFCD582AFQ40186543-D876ECB1-E48B-47DB-8AD8-89DFF3533117Q40230764-F77F48DF-DFE4-494C-B0B8-9731D8A4A417Q45873817-5C90E234-76ED-4B68-94BA-E6F84C38F9DCQ58801177-48C0180E-06DC-4A16-BFF2-65D0B8797F2D
P2860
Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@ast
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@en
type
label
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@ast
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@en
prefLabel
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@ast
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@en
P2093
P2860
P921
P356
P1433
P1476
Biological activities of a rec ...... ase 1 colorectal cancer trial.
@en
P2093
Atencio IA
Horowitz JA
Hutchins B
Indelicato S
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700870
P577
2006-02-01T00:00:00Z
P5875
P6179
1016883463